These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 1905419)
1. [Detection of anti-Ro(SS-A) by using immunoimprint. Comparison with double diffusion in agar. Apropos of a series of 63 primary Gougerot-Sjögren syndromes]. Meyer O; Haim T; Bourgeois P; Palazzo E; Ribard P; Belmatoug N; Kahn MF Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):149-55. PubMed ID: 1905419 [TBL] [Abstract][Full Text] [Related]
2. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome. Hansen B; Manthorpe R Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875 [TBL] [Abstract][Full Text] [Related]
3. [Soluble SS-A, SS-B and RNP antinuclear antigen antibodies in 66 cases of pure or associated forms of Gougerot-Sjögren syndrome]. Meyer O; Chabrand-Ahond L; Kahn MF; Ryckewaert A Rev Rhum Mal Osteoartic; 1982 May; 49(6):421-5. PubMed ID: 6810443 [TBL] [Abstract][Full Text] [Related]
4. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance]. Miyawaki S Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349 [TBL] [Abstract][Full Text] [Related]
5. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La. Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924 [TBL] [Abstract][Full Text] [Related]
6. [Comparative profile of antinuclear antibodies in Gougerot-Sjögren syndrome with and without diffuse interstitial pulmonary fibrosis]. Barranquero-Beltrán A; Meyer O; Haim T; Kaplan G; Kahn MF Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):615-9. PubMed ID: 3497426 [TBL] [Abstract][Full Text] [Related]
7. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome. Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253 [TBL] [Abstract][Full Text] [Related]
9. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Provost TT; Talal N; Harley JB; Reichlin M; Alexander E Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371 [TBL] [Abstract][Full Text] [Related]
10. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. Tishler M; Moutsopoulos HM; Yaron M J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820 [TBL] [Abstract][Full Text] [Related]
11. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome. Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the RNA and protein components recognized by anti-La(SS-B) autoantibodies. McNeilage LJ; Whittingham S; Jack I; MacKay IR Clin Exp Immunol; 1985 Dec; 62(3):685-95. PubMed ID: 2417765 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients. Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome. Locht H; Pelck R; Manthorpe R J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression. Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127 [TBL] [Abstract][Full Text] [Related]
17. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526 [TBL] [Abstract][Full Text] [Related]
18. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases. Yamagata H; Akizuki M; Tojo T; Homma M Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876 [TBL] [Abstract][Full Text] [Related]
19. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome. Lee M; Rutka JA; Slomovic AR; McComb J; Bailey DJ; Bookman AA J Rheumatol; 1998 Feb; 25(2):247-53. PubMed ID: 9489815 [TBL] [Abstract][Full Text] [Related]
20. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies. Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]